Ballast Point Ventures — 2013 Investments
1 investments dated 2013 · listed companies and verified rows first · show all
BioTissuebiotissue.cominSeries A · Aug 2013 · $10M✓ verified
BioTissue develops regenerative medicine products derived from human birth tissue to treat wounds and chronic pain.
BiotechHealthtechMedical DevicesMiami, US
Scheffer C.G. Tseng(Chief Scientific Officer)
Co-investorsEssex Woodlands Healthcare Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.